Fate Therapeutics, Inc. (FATE)
2.11
+0.02
(+0.96%)
USD |
NASDAQ |
Oct 23, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Market Cap : 246.22M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 246.22M |
| October 22, 2026 | 243.89M |
| October 21, 2026 | 241.56M |
| October 20, 2026 | 240.39M |
| October 19, 2026 | 217.05M |
| October 16, 2026 | 208.88M |
| October 15, 2026 | 224.64M |
| October 14, 2026 | 226.39M |
| October 13, 2026 | 233.39M |
| October 12, 2026 | 248.56M |
| October 09, 2026 | 254.39M |
| October 08, 2026 | 248.56M |
| October 07, 2026 | 250.89M |
| October 06, 2026 | 267.23M |
| October 05, 2026 | 283.57M |
| October 02, 2026 | 270.73M |
| October 01, 2026 | 268.40M |
| September 30, 2026 | 276.56M |
| September 29, 2026 | 277.73M |
| September 28, 2026 | 277.73M |
| September 25, 2026 | 274.23M |
| September 24, 2026 | 271.90M |
| September 23, 2026 | 283.57M |
| September 22, 2026 | 301.07M |
| September 21, 2026 | 295.24M |
| Date | Value |
|---|---|
| September 18, 2026 | 295.24M |
| September 17, 2026 | 294.07M |
| September 16, 2026 | 284.73M |
| September 15, 2026 | 274.23M |
| September 14, 2026 | 273.06M |
| September 11, 2026 | 269.56M |
| September 10, 2026 | 271.90M |
| September 09, 2026 | 284.73M |
| September 08, 2026 | 291.74M |
| September 04, 2026 | 289.40M |
| September 03, 2026 | 282.40M |
| September 02, 2026 | 285.90M |
| September 01, 2026 | 283.57M |
| August 31, 2026 | 278.90M |
| August 28, 2026 | 283.57M |
| August 27, 2026 | 296.40M |
| August 26, 2026 | 299.90M |
| August 25, 2026 | 297.57M |
| August 24, 2026 | 284.73M |
| August 21, 2026 | 271.90M |
| August 20, 2026 | 285.90M |
| August 19, 2026 | 309.24M |
| August 18, 2026 | 298.74M |
| August 17, 2026 | 305.74M |
| August 14, 2026 | 299.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| PS Ratio | 38.90 |
| Price to Book Value | 1.605 |
| Price | 2.11 |
| Earnings Yield | -49.91% |